VAERS Explorer
Back to explore

Report #2864487

Received Oct 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TN
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
DTDT ADSORBED (NO BRAND NAME)UNKNOWN MANUFACTURERUNK—OT
TDAPTDAP (ADACEL)SANOFI PASTEURUNK—OT

Symptoms (2)

No adverse eventWrong product administered

Symptom narrative

inappropriate use due to administration of wrong medication with no reported adverse event; Initial information received on 03-Oct-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient who received Diphtheria Toxoid Instead Of Diphtheria-2/Tetanus/5 AC Pertussis Vaccine [Adacel] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Diphtheria Toxoid produced by unknown manufacturer (lot number, formulation, strength and expiry date-unknown) via unknown route in unknown administration site for prophylactic vaccination (Immunisation) instead of Diphtheria-2/Tetanus/5 AC Pertussis Vaccine with no reported ae (adverse event) (wrong product administered) (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.